These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2013100)

  • 1. Interleukin-4 enhances anti-IgM stimulation of B cells by improving cell viability and by increasing the sensitivity of B cells to the anti-IgM signal.
    Hodgkin PD; Go NF; Cupp JE; Howard M
    Cell Immunol; 1991 Apr; 134(1):14-30. PubMed ID: 2013100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The requirements for growth of in vivo activated autoimmune B cells are similar to those of in vitro generated lipopolysaccharide B cell blasts and dissimilar to anti-IgM plus IL-4 induced B lymphoblasts.
    Cabrero E; Sánchez MJ; Gutiérrez C
    J Autoimmun; 1992 Jun; 5(3):289-303. PubMed ID: 1388636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-4-mediated aggregation of anti-IgM-stimulated human B cells: inhibition of aggregation but enhancement of proliferation by antibodies to LFA-1.
    Björck P; Paulie S; Axelsson B
    Immunology; 1992 Jan; 75(1):122-8. PubMed ID: 1537588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes.
    Solvason N; Wu WW; Kabra N; Wu X; Lees E; Howard MC
    J Exp Med; 1996 Aug; 184(2):407-17. PubMed ID: 8760794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difference in apoptosis induction between surface IgD and IgM.
    Peckham D; Andersen-Nissen E; Finkelman FD; Stunz LL; Ashman RF
    Int Immunol; 2001 Mar; 13(3):285-95. PubMed ID: 11222497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of anti-immunoglobulin antibodies, interleukin-4 and second messenger agonists on B cells from neonatal mice.
    Brines RD; Klaus GG
    Int Immunol; 1991 May; 3(5):461-6. PubMed ID: 1832947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin A and FK506 block the negative signaling mediated by surface IgM cross-linking in normal human mature B cells.
    Yamaoka K; Kim KM; Ishigami T; Higaki Y; Hata D; Katamura K; Mayumi M; Mikawa H
    Immunol Lett; 1993 May; 36(2):203-8. PubMed ID: 7688712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell growth-promoting activity of recombinant human interleukin 4.
    Defrance T; Vanbervliet B; Aubry JP; Takebe Y; Arai N; Miyajima A; Yokota T; Lee F; Arai K; de Vries JE
    J Immunol; 1987 Aug; 139(4):1135-41. PubMed ID: 3112225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential activity of recombinant lymphokines on mouse B cell proliferation and cell cycle progression are revealed by 5-bromo-2'-deoxyuridine/Hoechst 33258 dye flow cytometry.
    Seyschab H; Hoehn H; Rabinovitch PS; Chen U
    Eur J Immunol; 1991 Sep; 21(9):2153-60. PubMed ID: 1909644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separate control of B lymphocyte early activation and proliferation in response to anti-IgM antibodies.
    DeFranco AL; Raveche ES; Paul WE
    J Immunol; 1985 Jul; 135(1):87-94. PubMed ID: 3873499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirements of a costimulus for IL-4-induced IgE class switching in murine B cells activated via antigen receptors: effectiveness of 8-mercaptoguanosine.
    Hikida M; Takai T; Ohmori H
    J Immunol; 1996 Apr; 156(8):2730-6. PubMed ID: 8609390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phorbol myristate acetate inhibits anti-IgM-mediated signaling in resting B cells.
    Mizuguchi J; Beaven MA; Li JH; Paul WE
    Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4474-8. PubMed ID: 3086884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-IgM but not anti-IgD antibodies inhibit cell division of normal human mature B cells.
    Kim KM; Ishigami T; Hata D; Higaki Y; Morita M; Yamaoka K; Mayumi M; Mikawa H
    J Immunol; 1992 Jan; 148(1):29-34. PubMed ID: 1727873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell stimulatory factor 1 (BSF-1) prepares resting B cells to enter S phase in response to anti-IgM and lipopolysaccharide.
    Rabin EM; Mond JJ; Ohara J; Paul WE
    J Exp Med; 1986 Aug; 164(2):517-31. PubMed ID: 3487616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant IL 2 but not recombinant interferon-gamma stimulates both proliferation and IgM secretion in a Ly-1+ clone of neoplastic murine B cells (BCL1).
    Brooks KH; Vitetta ES
    J Immunol; 1986 Nov; 137(10):3205-10. PubMed ID: 2945863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-cell stimulatory factor 1 activates resting B cells.
    Rabin EM; Ohara J; Paul WE
    Proc Natl Acad Sci U S A; 1985 May; 82(9):2935-9. PubMed ID: 3873071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant murine IL-5 induces high rate IgA synthesis in cycling IgA-positive Peyer's patch B cells.
    Beagley KW; Eldridge JH; Kiyono H; Everson MP; Koopman WJ; Honjo T; McGhee JR
    J Immunol; 1988 Sep; 141(6):2035-42. PubMed ID: 3262647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of BrdU/Hoechst-ethidium bromide two parameter flow cytometry in studying synchronous and non-synchronous mouse cells.
    Chen U
    Immunobiology; 1992 Aug; 185(2-4):366-79. PubMed ID: 1280619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isotype switching in anti-immunoglobulin-activated B lymphoblasts: differential requirements for interleukin 4 and other lymphokines to elicit membrane vs. secreted IgG1.
    Purkerson JM; Isakson PC
    Eur J Immunol; 1991 Mar; 21(3):707-14. PubMed ID: 2009912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 4 inhibits the proliferation but not the differentiation of activated human B cells in response to interleukin 2.
    Defrance T; Vanbervliet B; Aubry JP; Banchereau J
    J Exp Med; 1988 Oct; 168(4):1321-37. PubMed ID: 3262709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.